Optimising Breast Cancer Outcomes: From clinical to real-world experience with KRYXANA®
Join the event:
For optimum viewing please make use of either Google Chrome or
Firefox as your web browser to view the stream.
Please take note of the webinar dates:
Wednesday 8th of July 16h00
Thursday 9th of July 18h30
Saturday 11th of July 09h00
Please post any questions you may have during the presentation in the live chat feature
in the upper right corner of the video window.
Dr Javier Cortés, MD
Javier Cortés, MD, received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996. He continued his studies at the University of Navarra, specialising in Medical Oncology at the Clínica Universitaria de Navarra, where he continued as Assistant in the Department of Oncology from 2002. He was Associated Professor of Oncology in the Faculty of Medicine at the University of Navarra during that period.
Dr. Cortés was awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. From June 2003 to July 2015, he has worked in the Department of Medical Oncology at the Hospital Vall d’Hebron, Barcelona, where he has been Coordinator of the Teaching and Training Programme for Residents in Oncology and Senior Specialist in the Area of Breast Cancer with a special interest in New Drugs Development.
Dr. Cortés was the Head of the Breast Cancer Program and the Melanoma Unit from July 2006 to August 2015. From September 2015 to October 2018, he has been Head of the Breast Cancer and Gynecological tumors at Ramon y Cajal University Hospital in Madrid. He is Clinical Investigator of the Breast Cancer Research Program at Vall d’Hebron Institute of Oncology, and Head of Breast Cancer Program, IOB Institute of Oncology, Madrid and Barcelona, Spain.
In addition to his medical specialties, he has two masters’ degree in “Medical Direction and Clinical Management” by the Universidad Nacional de Educación a Distancia (UNED) and “Research methodology in Health Sciences” by the Universidad Autonoma de Barcelona and a degree in “Statistics in Health Sciences” by the Universidad Autonoma de Barcelona.
Dr. Cortés is the author of more than 230 publications, especially about breast tumours and new drugs and more than 500 communications at different conferences. He actively participates in the development of numerous national and international clinical investigations, especially in relation to drugs directed against molecular targets and new chemotherapy agents, and he is an ad hoc reviewer of various oncology journals.
Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO), American Association for Cancer research (AACR) and a member of the Scientific Committee of the European Society of Medical Oncology.
|10 minutes||Welcome and introduction||Shelley Horner: Novartis Country President|
|20 minutes||Clinical overview of the MONALEESA trials||Dr Cortés|
Case Studies With Practical Guidelines
|10 minutes||“Can Premenopausal Patients Live Longer ?” MONALEESA 7||Dr Cortés|
|10 minutes||Different endocrine partner, Consistent Results in a Postmenopausal Patient MONALEESA 2||Dr Cortés|
|10 minutes||“What about overall survival in Postmenopausal Patients?” MONALEESA 3||Dr Cortés|
|15 minutes||How to optimise treatment with KRYXANA®||Dr Cortés|